Ghana FDA approves Vanessa for antidiarrheal trials
Vanessa Biotech has been granted regulatory approval from the Ghana FDA to conduct Phase 2 clinical trials for VR-AD-1005, a novel antidiarrheal investigational drug. The Phase...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Vanessa Biotech has been granted regulatory approval from the Ghana FDA to conduct Phase 2 clinical trials for VR-AD-1005, a novel antidiarrheal investigational drug. The Phase...
Bioscience leaders outlined the challenges of bringing their discoveries to market and growing in New Haven as part of a panel discussion with public officials...
New Haven-based Artizan Biosciences recently appointed Dr. Bridget Martell to serve as the company’s new president and CEO. Martell has an extensive background in the...
Scientists at Alexion have made it their mission to pioneer new scientific breakthroughs to transform the treatment of rare diseases and devastating conditions. But delivering...
Following its acquisition by drug giant AstraZeneca, New Haven-born Alexion Pharmaceuticals is growing its drug pipeline, agreeing to pay up to $500 million for New Jersey-based Caelum...
IsoPlexis, a Branford-based life science technology company, went public in early October, with its stock initially trading at $15 a share. The company’s stock is listed...
A five-year-old Yale program that has helped dozens of drug and medical device companies get their ideas off the ground is now looking to help...
UConn Associate Professor of Medicine Anne Delany has received a $2.2 million grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases to...
Biorez reports four new patents relating to Biorez’s proprietary BioBrace™ Implant, which is a biocomposite soft tissue scaffold intended to reinforce soft tissue repair, and act as a...
By Bill Claffey, tax attorney and partner at the accounting firm Fiondella, Milone and LaSaracina LLP (FML) The Connecticut R&D tax credit allows corporations to...